Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04428333 |
Title | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
Acronym | INDUCE-4 |
Recruitment | Terminated |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | SWE | ROU | POL | ITA | IRL | GBR | FRA | ESP | DNK | DEU | CAN | BRA | BEL | AUS | ARG |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
GSK Investigational Site | Buenos Aires | 1012 | Argentina | Details | ||
GSK Investigational Site | Ciudad AutOnoma de Buenos Aires | C1426ABP | Argentina | Details | ||
GSK Investigational Site | Oro Verde Entre RIos | E3100XAD | Argentina | Details | ||
GSK Investigational Site | Rosario | S2000DBS | Argentina | Details | ||
GSK Investigational Site | San Miguel de TucumAn | T4000 | Argentina | Details | ||
GSK Investigational Site | Blacktown | 2148 | Australia | Details | ||
GSK Investigational Site | Heidelberg | 3084 | Australia | Details | ||
GSK Investigational Site | Melbourne | 3000 | Australia | Details | ||
GSK Investigational Site | Woolangabba | 4102 | Australia | Details | ||
GSK Investigational Site | Bruxelles | 1070 | Belgium | Details | ||
GSK Investigational Site | Edegem | 2650 | Belgium | Details | ||
GSK Investigational Site | Curitiba | 81520-060 | Brazil | Details | ||
GSK Investigational Site | SAo Paulo | 01246-000 | Brazil | Details | ||
GSK Investigational Site | VitOria | 29043-260 | Brazil | Details | ||
GSK Investigational Site | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
GSK Investigational Site | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
GSK Investigational Site | London | Ontario | N6A 4G5 | Canada | Details | |
GSK Investigational Site | Toronto | Ontario | M4N 3M5 | Canada | Details | |
GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
GSK Investigational Site | Montreal | Quebec | H2X 3E4 | Canada | Details | |
GSK Investigational Site | Koebenhavn | 2100 | Denmark | Details | ||
GSK Investigational Site | Bordeaux | 33000 | France | Details | ||
GSK Investigational Site | Lyon cedex 08 | 69373 | France | Details | ||
GSK Investigational Site | Paris | 75005 | France | Details | ||
GSK Investigational Site | Poitiers | 86021 | France | Details | ||
GSK Investigational Site | Strasbourg | 67200 | France | Details | ||
GSK Investigational Site | Berlin | 12203 | Germany | Details | ||
GSK Investigational Site | Hannover | 30625 | Germany | Details | ||
GSK Investigational Site | Leipzig | 04103 | Germany | Details | ||
GSK Investigational Site | Ulm | 89075 | Germany | Details | ||
GSK Investigational Site | Dublin | 8 | Ireland | Details | ||
GSK Investigational Site | Brescia | 25123 | Italy | Details | ||
GSK Investigational Site | Firenze | 59100 | Italy | Details | ||
GSK Investigational Site | Milano | 20132 | Italy | Details | ||
GSK Investigational Site | Napoli | 80131 | Italy | Details | ||
GSK Investigational Site | Roma | 00144 | Italy | Details | ||
GSK Investigational Site | Savona | 17100 | Italy | Details | ||
GSK Investigational Site | Osaka | 541-8567 | Japan | Details | ||
GSK Investigational Site | Osaka | 589-8511 | Japan | Details | ||
GSK Investigational Site | Tokyo | 104-0045 | Japan | Details | ||
GSK Investigational Site | Tokyo | 135-8550 | Japan | Details | ||
GSK Investigational Site | Daegu | 42601 | Korea, Republic of | Details | ||
GSK Investigational Site | Gyeonggi-do | 10408 | Korea, Republic of | Details | ||
GSK Investigational Site | Hwasun | 58128 | Korea, Republic of | Details | ||
GSK Investigational Site | Incheon | 21565 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 05505 | Korea, Republic of | Details | ||
GSK Investigational Site | Seoul | 137-701 | Korea, Republic of | Details | ||
GSK Investigational Site | Bydgoszcz | 85-796 | Poland | Details | ||
GSK Investigational Site | Gdynia | 81-519 | Poland | Details | ||
GSK Investigational Site | Gliwice | 44-102 | Poland | Details | ||
GSK Investigational Site | Lublin | 20-090 | Poland | Details | ||
GSK Investigational Site | Tomaszow Mazowiecki | 97-200 | Poland | Details | ||
GSK Investigational Site | Warszawa | 02-781 | Poland | Details | ||
GSK Investigational Site | Bucuresti | 021389 | Romania | Details | ||
GSK Investigational Site | Cluj Napoca | 400015 | Romania | Details | ||
GSK Investigational Site | Craiova | 200347 | Romania | Details | ||
GSK Investigational Site | Floresti | 407280 | Romania | Details | ||
GSK Investigational Site | Otopeni | 075100 | Romania | Details | ||
GSK Investigational Site | Suceava | 720284 | Romania | Details | ||
GSK Investigational Site | Pushkin | 196603 | Russian Federation | Details | ||
GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
GSK Investigational Site | Madrid | 28041 | Spain | Details | ||
GSK Investigational Site | Madrid | 28046 | Spain | Details | ||
GSK Investigational Site | Madrid | 28050 | Spain | Details | ||
GSK Investigational Site | Valencia | 46026 | Spain | Details | ||
GSK Investigational Site | Stockholm | SE-171 64 | Sweden | Details | ||
GSK Investigational Site | London | SW3 6JJ | United Kingdom | Details | ||
GSK Investigational Site | Nottingham | NG5 1PB | United Kingdom | Details | ||
GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |
CKB CORE allows for only a limited number of monthly page views for un-registered users. However, registration is free and allows for unlimited browsing of the CKB CORE content.
You have reached the monthly page view limit. For continued free access to CKB CORE, please register below: